| IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2 JP Upton, L Wang, D Han, ES Wang, NE Huskey, L Lim, M Truitt, ... Science 338 (6108), 818-822, 2012 | 721 | 2012 |
| CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ... Cancer discovery 8 (2), 216-233, 2018 | 605 | 2018 |
| Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress R Ghosh, L Wang, ES Wang, BGK Perera, A Igbaria, S Morita, K Prado, ... Cell 158 (3), 534-548, 2014 | 484 | 2014 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 460 | 2018 |
| Development of dual and selective degraders of cyclin‐dependent kinases 4 and 6 B Jiang, ES Wang, KA Donovan, Y Liang, ES Fischer, T Zhang, NS Gray Angewandte Chemie International Edition 58 (19), 6321-6326, 2019 | 215 | 2019 |
| Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML M Brand, B Jiang, S Bauer, KA Donovan, Y Liang, ES Wang, RP Nowak, ... Cell chemical biology 26 (2), 300-306. e9, 2019 | 211 | 2019 |
| CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer H Zhang, CL Christensen, R Dries, MG Oser, J Deng, B Diskin, F Li, Y Pan, ... Cancer cell 37 (1), 37-54. e9, 2020 | 175 | 2020 |
| Bruton tyrosine kinase degradation as a therapeutic strategy for cancer D Dobrovolsky, ES Wang, S Morrow, C Leahy, T Faust, RP Nowak, ... Blood, The Journal of the American Society of Hematology 133 (9), 952-961, 2019 | 154 | 2019 |
| Development of highly potent and selective steroidal inhibitors and degraders of CDK8 JM Hatcher, ES Wang, L Johannessen, N Kwiatkowski, T Sim, NS Gray ACS medicinal chemistry letters 9 (6), 540-545, 2018 | 87 | 2018 |
| ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer J Deng, A Thennavan, I Dolgalev, T Chen, J Li, A Marzio, JT Poirier, ... Nature cancer 2 (5), 503-514, 2021 | 81 | 2021 |
| Inhibition of CDK4/6 promotes CD8 T-cell memory formation M Heckler, LR Ali, E Clancy-Thompson, L Qiang, KS Ventre, P Lenehan, ... Cancer discovery 11 (10), 2564-2581, 2021 | 78 | 2021 |
| Acute pharmacological degradation of Helios destabilizes regulatory T cells ES Wang, AL Verano, RP Nowak, JC Yuan, KA Donovan, NA Eleuteri, ... Nature chemical biology 17 (6), 711-717, 2021 | 65 | 2021 |
| Selective degradation of GSPT1 by cereblon modulators identified via a focused combinatorial library CE Powell, G Du, J Che, Z He, KA Donovan, H Yue, ES Wang, RP Nowak, ... ACS chemical biology 15 (10), 2722-2730, 2020 | 63 | 2020 |
| Fas-activated mitochondrial apoptosis culls stalled embryonic stem cells to promote differentiation ES Wang, NA Reyes, C Melton, NE Huskey, O Momcilovic, A Goga, ... Current Biology 25 (23), 3110-3118, 2015 | 25 | 2015 |
| PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion JL Hope, DC Otero, EA Bae, CJ Stairiker, AB Palete, HA Faso, M Lin, ... Cell reports 42 (5), 2023 | 10 | 2023 |
| Reexamination of the cysteine residues in glucocerebrosidase R Moharram, D Maynard, ES Wang, A Makusky, GJ Murray, BM Martin FEBS letters 580 (14), 3391-3394, 2006 | 10 | 2006 |
| Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation I You, KA Donovan, NM Krupnick, AS Boghossian, MG Rees, MM Ronan, ... Cell chemical biology 29 (11), 1630-1638. e7, 2022 | 9 | 2022 |
| Development of highly potent and selective pyrazolopyridine inhibitor of CDK8/19 JM Hatcher, PS Vatsan, E Wang, J Jiang, NS Gray ACS Medicinal Chemistry Letters 12 (11), 1689-1693, 2021 | 8 | 2021 |
| Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use NS Gray, T Zhang, CM Olson, Y Liang, N Kwiatkowski, B Jiang, E Wang US Patent 10,865,204, 2020 | 8 | 2020 |
| Development of potent and selective degraders of PI5P4Kγ W Ji, ES Wang, TD Manz, J Jiang, KA Donovan, X Abulaiti, ES Fischer, ... European journal of medicinal chemistry 247, 115027, 2023 | 5 | 2023 |
